NATCO Pharma

BSE : 524816 | NSE : NATCOPHARM

Industry : Pharmaceuticals | ISIN : INE987B01026 | FreeFloat : 45.00% | FnO : No | LotSize : N/A


Intellectual Capital (IC)657.46
Net Worth (NW)4,303.21
Intrinsic Worth (IW)4,960.67
Market Cap (MC)16,497.67
Economic Value Added-45.20
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)13.25%
IC Gross Margin (EBITDA/IC)90.12%
IC Net Margin (NPT/IC)54.06%
Knowledge Turnover (Sales/IC)2.87
Market to Intrinsic Value (MC/IW)3.33

As OfIntrinsic ValueMarket Price
31 Dec 2021Rs. 272.02Rs. 904.65
18 May 2022 ---- Rs. 715.15
-3.85     -0.54%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 715.86SellStrong Sell
KB > 50% : No50 DMA : Rs. 788.60
0 < M2IV < 1 : NoVol-Price trend : Falling

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Mar-19
C
455.70
486.70
179.30
157.60
152.40
120.40
117.00
Jun-19
C
492.30
513.30
212.30
190.30
183.80
142.80
144.50
Sep-19
C
485.70
518.90
167.50
145.60
139.40
117.70
118.60
Dec-19
C
482.20
513.00
159.50
134.10
128.80
104.40
105.00
Mar-20
C
454.80
477.20
150.70
120.20
116.70
93.20
75.50
Jun-20
C
563.40
582.10
189.80
161.80
158.10
122.10
124.20
Sep-20
C
802.20
827.90
302.10
273.40
270.70
203.90
193.30
Dec-20
C
355.20
386.00
113.30
83.50
80.10
63.40
67.00
Mar-21
C
331.30
359.70
104.60
74.20
70.70
53.00
53.90
Jun-21
C
410.30
427.30
126.80
93.00
91.00
75.00
73.00
Sep-21
C
377.20
415.20
108.50
73.80
69.80
65.10
60.60
Dec-21
C
560.50
590.70
132.00
96.00
91.00
80.40
77.80
* C - Consolidated, S - Standalone